Bluebird Bio
(NASDAQ) BLUE
Bluebird Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$103.95M
Net Income (TTM)
$199.98M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BLUE News
Is Bluebird Bio Stock a Buy?
BLUE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bluebird Bio
Industry
Biotechnology
Sector
Health CareEmployees
248
CEO
Andrew Obenshain, MBA
Website
www.bluebirdbio.comHeadquarters
Cambridge, MA 02142, US
BLUE Financials
Key Financial Metrics (TTM)
Gross Margin
47%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
4%
Return on Capital
7%
Return on Assets
-40%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$5.57M
Operating Income
$270.46M
EBITDA
$156.82M
Operating Cash Flow
$260.02M
Capital Expenditure
$2.60M
Free Cash Flow
$262.62M
Cash & ST Invst.
$62.30M
Total Debt
$358.24M
Bluebird Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$38.71M
+108.4%
Gross Profit
$26.48M
+463.1%
Gross Margin
68.39%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
248
N/A
Net Income
$29.07M
+58.4%
EBITDA
$7.68M
+84.5%
Quarterly Fundamentals
Net Cash
$109.40M
+45.9%
Accounts Receivable
$4.06M
-77.1%
Inventory
$83.28M
+174.8%
Long Term Debt
$38.65M
-81.3%
Short Term Debt
$149.49M
-28.0%
Return on Assets
-40.07%
N/A
Return on Invested Capital
6.69%
N/A
Free Cash Flow
$44.30M
+42.1%
Operating Cash Flow
$43.44M
+41.8%